Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland G R, Lanier L L, Phillips J H
DNAX Research Institute of Molecular and Cellular Biology, Department of Human Immunology, Palo Alto, California 94304-1104, USA.
Immunity. 1996 Jun;4(6):573-81. doi: 10.1016/s1074-7613(00)70060-4.
Intercellular adhesion molecules play an important role in the generation of T lymphocyte-mediated immune responses. Here, we describe a novel accessory molecule, DNAX accessory molecule-1 (DNAM-1), that is constitutively expressed on the majority of peripheral blood T lymphocytes. DNAM-1 is a 65 kDa transmembrane glycoprotein consisting of 318 aa including two immunoglobulin-like domains. Anti-DNAM-1 monoclonal antibody (MAb) inhibits T and NK cell-mediated cytotoxicity against a variety of tumor cell targets and blocks cytokine production by alloantigen-specific T cells. In addition, DNAM-1 is a tyrosine-phosphorylated signal-transducing molecule that participates in primary adhesion during cytotoxic T lymphocyte (CTL)-mediated cytotoxicity.
细胞间黏附分子在T淋巴细胞介导的免疫反应产生过程中发挥重要作用。在此,我们描述了一种新型辅助分子,即DNAX辅助分子-1(DNAM-1),它在大多数外周血T淋巴细胞上组成性表达。DNAM-1是一种65 kDa的跨膜糖蛋白,由318个氨基酸组成,包括两个免疫球蛋白样结构域。抗DNAM-1单克隆抗体(MAb)可抑制T细胞和NK细胞介导的对多种肿瘤细胞靶标的细胞毒性,并阻断同种异体抗原特异性T细胞产生细胞因子。此外,DNAM-1是一种酪氨酸磷酸化的信号转导分子,参与细胞毒性T淋巴细胞(CTL)介导的细胞毒性过程中的初始黏附。